Gene methylation in cancer diagnosis
US7960112B2 · kind B2 · utility
2Cited by
1References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2008 |
| Grant date | Jun 14, 2011 |
| Priority date | — |
| Expiry date | Jul 22, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/154
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.